期刊文献+

胰岛素对2型糖尿病合并冠心病患者心肌微循环的影响 被引量:4

Influence of insulin on myocardial microcirculation in patients with type 2 diabetes mellitus complicated coronary heart disease
下载PDF
导出
摘要 目的:通过比较冠心病合并2型糖尿病患者冠脉介入治疗(PCI)术后选择胰岛素还是口服降糖药治疗来研究胰岛素对微循环的影响。方法:入组65例冠脉造影明确冠心病且经压力导丝测定心肌血流储备分数(FFR)<0.75的患者,植入药物支架后测量微循环阻力指数(IMR),按目前是否应用胰岛素分为联合胰岛素治疗组(胰岛素组,30例)和单纯口服降糖药治疗组(单纯降糖药组,35例),随访半年,复查IMR,比较二者对心肌微循环的影响。结果:两组的主要心血管不良事件(MACEs)发生率无明显统计学差异(P=0.07)。胰岛素组术后半年的IMR水平较单纯降糖药组显著降低[(24.5±3.1)U比(30.2±4.3)U,P<0.05]。结论:冠心病合并2型糖尿病患者介入治疗术后胰岛素治疗能显著改善心肌微循环。 Objective: To study influence of insulin on myocardial microcirculation of patients with coronary heart disease (CHD) complicated type 2 diabetes mellitus (T2DM) after percutaneous coronary intervention (PCI). Meth- ods.. A total of 65 patients, who was confirmed as CHD by coronary angiography and fractional flow reserve (FFR) d0.75 measured by pressure guidewire, were enrolled. After drug-eluting stent implantation, index of microcireula- tion resistance (IMR) was measured. According to insulin usage or not, they were divided into insulin therapy group (insulin group, n = 30) and pure oral hypoglycemic agent therapy group (pure hypoglycemic agent group, n = 35). After six-month follow up, IMR was reviewed, and IMP, was compared between two groups. Results: There was no significant difference in incidence rate of major adverse cardiovascular events (MACEs) between two groups, P= 0. 07. On six months after PCI, IMR in insulin group was significantly lower than that of pure hypoglycemic agent group [ (24.5± 3.1) U vs. (30.2± 4. 3) U, P〈O. 05]. Conclusion: Insulin therapy can improve myocardial microcirculation in patients with coronary heart disease complicated type 2 diabetes mellitus after PCI.
出处 《心血管康复医学杂志》 CAS 2015年第4期366-369,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 血管阻力 糖尿病 2型 冠心病 Vascular resistance Diabetes mellitus, type 2 Coronary disease
  • 相关文献

参考文献14

  • 1Schneider DJ, Sobel BE. Determinants of coronary vascular dis- ease in patients with type II diabetes mellitus and their thera- peutic implications [J]. Clin Cardiol, 1997, 20 (5) : 433- 440.
  • 2梁建文,张东辉,吴剑胜.心肌血流储备分数评价糖尿病患者冠状动脉临界病变的可靠性[J].岭南心血管病杂志,2015,21(1):54-57. 被引量:2
  • 3Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation., superior reproducibility and less he-modynamic dependence of index of microcirculatory resistance compared with coronary flow reserve [J]. Circulation, 2006, 113 (17): 2054-2061.
  • 4Yanagisawa H, Chikamori T, Tanaka N, et al. Application of pressure-derived myocardial fractional flow reserve in assessing the functional severity of coronary artery stenosis in patients with diabetes mellitus [J]. CircJ, 2004, 68 (11): 993-998.
  • 5Pijls NH, Uijen GJ, Hoevelaken A, et al. Mean transit time for videodensitometric assessment of myocardial perfusion and the cencept of maximal flow ratio: a validation study in the in- tact dog and a pilot study in man [J]. Int J Card Imaging, 1990, 5 (2-3), 191-202.
  • 6Choi WG, Kim SH, Yoon HS, et al. Impact of anendothelial progenitor cell capturing stent on coronary microvascular func- tion: comparison with drug-eluting stents [J]. Korean J Intern Med, 2015, 30 (1): 42-48.
  • 7Lira HS, Yoon MH, Tahk SJ, et al. Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior my- ocardial infarctioni[J]. Eur Heart J,2009,30(23) :2854 - 2860.
  • 8Wong ND, Patao C, Malik S, et al. Preventable coronary heart disease events from control of cardiovascular risk factors in US adults with diabetes (projections from utilizing the UKPDS risk engine)[J].AmJ Cardiol,2014,113(8):1356- 1361.
  • 9余叶蓉.胰岛素的血管活性作用及其与内皮细胞功能的关系[J].中华内分泌代谢杂志,2002,18(4):323-325. 被引量:7
  • 10Lind L, Fugmann A, Branth S, et al. The impaimrent in en- dothelial function induced by non-esterfied fatty acids can be re- versed by insulin [J]. Clin Sci(Lond), 2000, 99(3) :169- 174.

二级参考文献43

  • 1郑莺,刘建平.糖尿病致冠状动脉粥样硬化的机制[J].心脏杂志,2007,19(3):347-350. 被引量:23
  • 2Bolti GB, Owen DR. Insulin glargine. Lancet 2000;356 (9228) :443 -445.
  • 3Rosenstock J. Schwarlz SL. Clark C. at al. Basal insulin thera- PY in type 2 diabetes: 27-week comparison of insulin glargine (HOM9OI)and NPH insulin. Diabetes Care 2001;24(11):631 - 636.
  • 4Houlden R. Harris S ,Yale JF,at al. Treatment satisfaction and quality of life with an early insulinizatlon strategy with insulin glargine compared to an adjusted oral therapy in the management of type 2 diabetes: the Canadian insight study. Value Health 2005 ;8 : A 172.
  • 5Schneider D J, Sobel BE. Detemlinants of coronary vascular disease in patients with type 2 diabetes mellitus and their therapeutic implications[J]. Clin Cardiol, 1997, 20(5) :433 -440.
  • 6Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantilative method of assessing coronary artery flow [ J ]. Circulation, 1996, 93 (5) :879 - 888.
  • 7Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology clinical expert consensus document on standardsfor acquisition, measurements, and reporting of intravascular ultrasound studies (IVUS) [ J ]. J Am Coll Cardiol, 2001, 37 (5) : 1478 - 1492.
  • 8TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trail [ J 1- N Engl J Med, 1985, 312 ( 9 ) :932 - 936.
  • 9GUSTO Investigators. An international randomized trial comparing 4 thrombolytic strategies for acute myocardial infaction [ J ]. N Engl J Med, 1993, 329(10) :673 -682.
  • 10Lind L, Fugnmnn A, Branth S, et al. The impairment in endothelial function by non-esterfied fatty acids can be reversed by insulin[ J]. Clin Sci, 2000, 99(3) :169 -174.

共引文献14

同被引文献28

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部